health
A scientist’s opinion : Interview with Marco Cavaleri about vaccine procedure
Marco Cavaleri is Head of Office, Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA). He is also the chair of the COVID-19 EMA pandemic Task Force and is responsible for EMA activities regarding emerging pathogens, vaccines and antimicrobial resistance. He is a pharmacologist who has spent several years in industry in ...
A scientist’s opinion : Interview with Prof Cristina Mussini about covid-19 treatment
Interview with Professor Cristina Mussini, Head of the Department of Infectious Diseases and Tropical Medicine at the University of Modena and Reggio Emilia in Italy and member of the European AIDS Clinical Society. She has been actively involved in various recent studies on the clinical use of tocilizumab in patients with COVID-19 pneumonia. First a ...
A scientist’s opinion : Interview with Dr Andrew Ip about covid-19 treatment
Interview with Dr Andrew Ip, a specialist in hematology/oncology at the John Theurer Cancer Center at Hackensack University Medical Center, USA, who has been involved in research on tocilizumab use in COVID-19 patients. Why did you choose tocilizumab to treat patients with COVID-19 pneumonia? Andrew Ip: Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 ...
A scientist’s opinion : Interview with Dr Juan Victor San-Martin Lopez about covid-19 treatment
Interview with Dr Juan Victor San-Martín López, a physician specialising in infectious diseases and a member of the task force coordinating responses to the leishmaniasis outbreak in 2011 and to COVID-19 at the Hospital Universitario de Fuenlabrada, Spain. He reports on his experience with tocilizumab use in COVID-19 patients. What is the so-called cytokine storm? ...
A scientist’s opinion : Interview with Prof Martijn van Hemert about covid-19 treatment
Interview with Martijn van Hemert, Associate professor and Principal Investigator in molecular virology and antiviral strategies at the Leiden University Medical Center. In recent years, his group has mainly been studying the Chikungunya and Zika viruses, but in the past he has also studied SARS-CoV. Since February 2020, he has shifted his focus to research ...
A scientist’s opinion : Interview with Dr Juan Pablo Horcajada about covid-19 treatment
Interview with Juan Pablo Horcajada, MD. is Head of the Department of Infectious Diseases and General Coordinator of the COVID-19 Service at the Hospital del Mar, Barcelona. Remdesivir is the first drug approved by the EMA to be used as part of the treatment of COVID-19 patients. How’s the use of this antiviral in your ...
From COVID-19 to climate change: seeing the issues beyond the news cycle
COVID-19 and climate change may seem to belong to different worlds. However, direct causal links can be discovered by looking through a systems thinking lens. How should journalists and science communicators report on complex issues like climate change?
Interview with Rasmus Kleis Nielsen, Director of the Reuters Institute for the Study of Journalism on Covid-19 misinformation
Rasmus Kleis Nielsen is Director of the Reuters Institute for the Study of Journalism. He is also Professor of Political Communication at the University of Oxford. He was previously Director of Research at the Reuters Institute and Editor-in-Chief of the International Journal of Press/Politics. His work focuses on changes in the news media, on political ...